Obesity, weight management, and health care costs: A primer

Disease Management

Volumn 10, Issue 3, 2007, Pages 129-137

  Bachman, Keith H ^a,b  

^a KAISER PERMANENTE   (United States)

^b Kaiser E Interstate Medical Office   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANOREXIGENIC AGENT; PHENTERMINE; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

ABSENTEEISM; BARIATRIC SURGERY; BEHAVIOR THERAPY; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH SERVICE; HUMAN; MEDICAL INFORMATION; OBESITY; POPULATION RESEARCH; REVIEW; RISK ASSESSMENT; TREATMENT DURATION; UNCERTAINTY; WEIGHT CONTROL;

BARIATRIC SURGERY; COST SAVINGS; COST-BENEFIT ANALYSIS; DECISION MAKING; DISEASE MANAGEMENT; HEALTH CARE COSTS; HUMANS; OBESITY; WEIGHT LOSS;

EID: 34548626605     PISSN: 1093507X     EISSN: None     Source Type: Journal    
DOI: 10.1089/dis.2007.103643     Document Type: Review

References (49)

1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295:1549-1555.
2. Sturm R. Increases in clinically severe obesity in the United States, 1986-2000. Arch Intern Med. 2003;163:2146-2183.
3. U.S. Preventive Services Task Force. Screening for obesity in adults: recommendations and rationale. Ann Intern Med. 2003;139:930-932.
4. Bish CL, Blanck HM, Serdula MK, Marcus M, Kohl HW, Kahn LK. Diet and physical activity behaviors among Americans trying to lose weight: 2000 Behavioral Risk Factor Surveillance System. Obes Res. 2005;13:596-607.
5. Federal Trade Commission. 2004 Weight Loss Advertising Survey. Available at: 〈www.ftc.gov/os/2005/04/050411weightlosssurvey04.pdf〉. Accessed April 2, 2007.
6. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724-1737.
7. National Institute for Healthcare Management Foundation. Health Plans Emerging as Pragmatic Partners in Fight Against Obesity. Available at: 〈www.nihcm.org/finalweb/ObesityReport.pdf〉. Accessed April 2, 2007.
8. Andreyeva T, Sturm R. Moderate and severe obesity have large differences in healthcare costs. Obes Res. 2004;12:1936-1943.
9. Arterburn DE, Maciejewski ML, Tsevat J. Impact of morbid obesity on medical expenditures in adults. Int J Obes (Lond). 2005;29:334-339.
10. Daviglus ML, Liu K, Yan LL, et al. Relation of body mass index in young adulthood and middle age to Medicare expenditures in older age. JAMA. 2004;292:2743-2749.
11. Finkelstein EA, Fiebelkorn IC, Wang G. National medical spending attributable to overweight and obesity: how much, and who's paying? Health Aff (Millwood). 2003 Jan-Jun;Suppl Web Exclusives:W3-219-26.
12. Musich SA, Lu C, McDonald T, Champagne LJ, Edington DW. Association of additional health risks on medical charges and prevalence of diabetes within body mass index categories. Am J Health Promot. 2004;18 264-268.
13. Quesenberry CP, Cann B, Jacobson A. Obesity health services use and health care costs among members of a health maintenance organization. Arch Int Med. 1998;58:466-472.
14. Raebel MA, Malone DC. Health services use and health care costs of obese and nonobese individuals. Arch Intern Med. 2004;154:2135-2140.
15. Pronk NP, Goodman MJ, O'Connor PJ, Martinson BC. Relationship between modifiable health risks and short-term health care charges. JAMA. 1999;282:2235-2239.
16. Sturm R. The effects of obesity, smoking and drinking on medical problems and costs. Health Affairs. 2002;21:245-253.
17. Thompson D, Brown JB, Nichols GA, Elmer PJ. Body mass index and future health care costs: a retrospective cohort study. Obes Res. 2001;9:210-218.
18. Wang F, Schultz AB, Musich S, McDonald T, Hirschland D, Edington DW. The relationship between National Heart, Lung, and Blood Institute Weight Guidelines and concurrent medical costs in a manufacturing population. Am J Health Promotion. 2003;17:183-189.
19. Wee CC, Phillips RS, Legedza AT, et al. Health care expenditures associated with overweight and obesity among US adults: importance of age and race. Am J Public Health. 2005;95:159-165.
20. Elmer PJ, Brown JB, Nichols GA, Oster G. Effects of weight gain on medical care costs. Intl J Obesity. 2004;28:1365-1373.
21. Gregg EW, Cheng YJ, Cadwell BL, et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA. 2005;293:1868-1874.
22. Thorpe KE, Florence CS, Howard DH, Joski P. The impact of obesity on rising medical spending. Health Aff (Millwood). 2004 Jul-Dec;Suppl Web Exclusives:W4-480-486. Health Affairs, 10.1377/hlthaff.w4.480.
23. Wang G, Dietz WH. Economic burden of obesity in youths aged 6 to 17 years: 1979-1999. Pediatrics. 2002;109:E81-1. Erratum in: Pediatrics. 2002;109:1195.
24. Tsai AG, Wadden TA. Systematic review: an evaluation of major commercial weight loss programs in the United States. Ann Intern Med. 2005;142:56-66.
25. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
26. Herman WH, Brandle M, Zhang P, et al. Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes Care. 2003;26:36-47.
27. Oster G, Thompson D, Edelsberg J, Bird AP, Colditz GA. Lifetime health and economic benefits of weight loss among obese persons. American Journal of Public Health. 1999;89:1536-1542.
28. Nichols GA, Brown JB, Stevens VG, Crawford J. Medical care costs reduction resulting from intentional weight loss. Paper presented at: 2004 North American Association for the Study of Obesity Conference; Nov 14-18, 2004; Las Vegas, NV.
29. Ramaswamy A, Gonzales R, Smith CD. Extensive preoperative testing is not necessary in morbidly obese patients undergoing gastric bypass. J Gastrointest Surg. 2004;8:159-164; discussion 164-165.
30. Encinosa WE, Bernard DM, Steiner CA, Chen CC. Use and costs of bariatric surgery and prescription weight-loss medications. Health Aff (Millwood). 2005;24:1039-1046.
31. Livingston EH. Hospital costs associated with bariatric procedures in the United States. Am J Surgery. 2005;190:816-820.
32. Encinosa WE, Bernard DM, Chen CC, Steiner CA. Health care utilization and outcomes after bariatric surgery. Med Care. 2006;44:706-712.
33. Zingmond DS, McGory ML, Ko CY. Hospitalization before and after gastric bypass surgery. JAMA. 2005;294:1918-1924.
34. Agren G, Narbro K, Jonsoon E, Naslund I, Sjostrom L, Peltonen M. Cost of in-patient care over 7 years among surgically and conventionally treated obese patients. Obes Res. 2002;10:1276-1283.
35. Sampalis JS, Liberman M, Auger S, Christou NV. The impact of weight reduction surgery on health-care costs in morbidly obese patients. Obes Surg. 2004;14:939-947.
36. Finkelstein EA, Brown D. A cost-benefit simulation model of coverage for bariatric surgery among full-time employees. Am J Manag Care. 2005;11:641-646.
37. Narbro K, Agren G, Jonsson E, Naslund I, Sjostrom L, Peltonen M. Pharmaceutical costs in obese individuals. Arch Intern Med. 2002;162:2061-2069.
38. Malone DC, Raebel MA, Porter JA, et al. Cost-effectiveness of sibutramine in the LOSE Weight Study: evaluating the role of pharmacologic weight-loss therapy within a weight management program. J Manag Care Pharm. 2005;11:458-468.
39. Stafford RS, Radley DC. National trends in antiobesity medication use. Arch Intern Med. 2003;163:1046-1050.
40. Eaton DK, Kann L, Kinchen S, Ross J, Hawkins J, Harris WA. Youth risk behavior surveillance-United States, 2005. MMWR Surveill Summ. 2006;55:1-108.
41. Avenell A, Broom J, Brown TJ, et al. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess. 2004;8:iii-iv, 1-182.
42. Salem L, Jensen CC, Flum DR. Are bariatric surgical outcomes worth their cost? A systematic Review. J Am Coll Surg. 2005;200:270-278.
43. Eddy DM, Schlessinger L, Kahn R. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes. Ann Intern Med. 2005;143:251-264.
44. Herman WH, Hoerger TJ, Brandle M, et al. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med. 2005;42:323-332.
45. Benjamin SM, Cadwell BL, Geiss LS, Engelgau MM, Vinocor F. A change in definition results in an increased number of adults with prediabetes in the United States. Arch Intern Med. 2004;164:2386.
46. Nichols GA, Brown JB. Higher medical care costs accompany impaired fasting glucose. Diabetes Care. 2005;28:2223-2229.
47. Roux L, Kuntz K, Donaldson C, Goldie SJ. Economic evaluations for weight loss interventions in overweight and obese women. Obesity. 2006;14:1093-1106.
48. Chapman LS. Meta-evaluation of worksite health promotion economic return studies: 2005 update. Am J Health Promot. 2005;19:1-11.
49. Aldana SG. Financial impact of health promotion programs: a comprehensive review of the literature. Am J Health Promot. 2001;15:296-320.